Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1197720170100020069
´ëÇÑÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸÁö
2017 Volume.10 No. 2 p.69 ~ p.79
Structure, Distribution, and Genetic Profile of ¥á-Synuclein and Their Potential Clinical Application in Parkinson¡¯s Disease
Si Xiaoli

Pu Jiali
Zhang Baorong
Abstract
Parkinson¡¯s disease (PD), the second most common neurodegenerative disorder after Alzheimer¡¯s disease, is characterized by the loss of nigral dopaminergic neurons. PD leads to a series of clinical symptoms, including motor and non-motor disturbances. ¥á-synuclein, the major component of Lewy bodies, is a hallmark lesion in PD. In this review, we concentrate on presenting the latest research on the structure, distribution, and function of ¥á-synuclein, and its interactions with PD. We also summarize the clinic applications of ¥á-synuclein, which suggest its use as a biomarker, and the latest progress in ¥á-synuclein therapy.
KEYWORD
Parkinson¡¯s disease, alpha-synuclein, pathogenic mechanism, biomarker, therapeutic strategy
FullTexts / Linksout information
 
Listed journal information